Document is current
Any future updates will be listed below
-
Authors
Clayman, Nancy
Eamranond, Pracha
Hanks, Helen
Mitcheff, Michael
RappaMannion, Lisa
York, Diane
Mattis, Paula
Guinen, Heidi
Carp, Alex
Olson, Laura
Bell, Kathleen
Shahi, Lydia
Saunders, Elizabeth
Lee, Joshua
Marsch, Lisa
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA047982, U01DA047982, U01DA047982, U01DA047982, U01DA047982, U01DA047982, U01DA047982, U01DA047982)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 25 March 2025
First Online: 8 April 2025
Declarations
:
: The New Hampshire Department of Corrections data was gathered as part of a quality improvement effort and therefore approval from an ethics board was not required. All materials and methods for the EXIT-CJS study were approved by the New York University School of Medicine Institutional Review Board.
: Dr. Lee has received in-kind study drug from Indivior and Alkermes for federally funded trials. Dr. Marsch is affiliated with Square2 Systems and is a consultant for Click Therapeutics and Boehringer Ingelheim. These relationships are extensively managed by her employer, Dartmouth College.
